Emergent BioSolutions (EBS) Tops Q3 EPS by 28c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $7.85 -1.88%
EPS Growth %: -31.3%
Financial Fact:
Contracts and grants: 31.5M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -31.3%
Financial Fact:
Contracts and grants: 31.5M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q3 EPS of $0.83, $0.28 better than the analyst estimate of $0.55. Revenue for the quarter came in at $164.9 million versus the consensus estimate of $151.42 million.
Emergent BioSolutions sees FY2015 revenue of $510-540 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
- AeroVironment restates quarterly financials, citing $89M goodwill error
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
